PT  - JOURNAL ARTICLE
AU  - E. Etchells
AU  - G. Sharpe
AU  - M. M. Burgess
AU  - P. A. Singer
TI  - Bioethics for clinicians: 2. Disclosure
DP  - 1996 Aug 15
TA  - Canadian Medical Association Journal
PG  - 387--391
VI  - 155
IP  - 4
4099  - http://www.cmaj.ca/content/155/4/387.short
4100  - http://www.cmaj.ca/content/155/4/387.full
SO  - CMAJ1996 Aug 15; 155
AB  - In the context of patient consent, "disclosure" refers to the provision of relevant information by the clinician and its comprehension by the patient. Both elements are necessary for valid consent. Disclosure should inform the patient adequately about the treatment and its expected effects, relevant alternative options and their benefits and risks, and the consequences of declining or delaying treatment. The clinician's goal is to disclose information that a reasonable person in the patient's position would need in order to make an informed decision. Therefore, clinicians may need to consider how the proposed treatment (and other options) might affect the patient's employment, finances, family life and other personal concerns. Clinicians may also need to be sensitive to cultural and religious beliefs that can affect disclosure.